Solid Biosciences Inc.
Price Action
Technical Summary
EMERGING TRENDSolid Biosciences Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 77), indicating performance broadly in line with the market. Earnings growth of 39% provides fundamental context to the price action. Investors should exercise caution due to high volatility (89% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $7.80 | -9.34% | BELOW |
| 50 SMA | $7.41 | -4.62% | BELOW |
| 100 SMA | $6.69 | +5.68% | ABOVE |
| 150 SMA | $6.24 | +13.38% | ABOVE |
| 200 SMA | $6.17 | +14.64% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SLDB in an uptrend right now?
SLDB has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is SLDB overbought or oversold?
SLDB's RSI (14) is 45. The stock is in neutral territory, neither overbought nor oversold.
Is SLDB outperforming the market?
SLDB has a Relative Strength (RS) Rating of 77 out of 99. SLDB is performing about average compared to the market.
Where is SLDB in its 52-week range?
SLDB is trading at $7.07, which is 80% of its 52-week high ($8.87) and 72% above its 52-week low ($2.41).
How volatile is SLDB?
SLDB has a Beta of 2.42 and 52-week volatility of 89%. It's more volatile than the S&P 500 - expect bigger swings.